Quick Takeaways
- This page summarizes Jack L. Wyszomierski's Form 4 filing for EXELIXIS, INC. (EXEL).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 27 May 2022, 20:19.
Jack L. Wyszomierski - 26 May 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Role
- Director
- Signature
- /s/ Nina Ayer, Attorney in Fact
- Issuer symbol
- EXEL
- Transactions as of
- 26 May 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 27 May 2022, 20:19:47 UTC
- Previous filing
- 20 May 2022
- Next filing
- 20 Sep 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Jack L. Wyszomierski filed Form 4 for EXELIXIS, INC. (EXEL) on 27 May 2022."
What Changed
- Previous filing in this sequence was filed on 20 May 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Common Stock | Award | $0 | +19,575 | +7.2% | $0.000000 | 292,767 | 26 May 2022 | Direct | F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. |
| F2 | The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 26, 2023, subject to the Reporting Person's continuous service through that date. |
| F3 | Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney